terazosin has been researched along with Ureteral Obstruction in 2 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, F | 1 |
| Man, LB | 1 |
| Li, GZ | 1 |
| Liu, N | 1 |
| Smith, PP | 1 |
| Hurtado, E | 1 |
| Smith, CP | 1 |
| Boone, TB | 1 |
| Somogyi, GT | 1 |
2 other studies available for terazosin and Ureteral Obstruction
| Article | Year |
|---|---|
Efficacy of α-blocker in improving ureteral stent-related symptoms: a meta-analysis of both direct and indirect comparison.
Topics: Adrenergic alpha-Antagonists; Humans; Pain Measurement; Pain, Postoperative; Prazosin; Quinazolines; | 2016 |
Comparison of cystometric methods in female rats.
Topics: Adrenergic alpha-Antagonists; Anesthesia, General; Animals; Female; Prazosin; Pressure; Rats; Rats, | 2008 |